Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis

Australas Psychiatry. 2005 Sep;13(3):247-52. doi: 10.1080/j.1440-1665.2005.02194.x.

Abstract

Objective: To describe the process underpinning the development of clinical guidelines for the management of behavioural disturbance in psychosis.

Method: A structured process was followed, encompassing a literature review, focus groups with key staff, and pilot testing and monitoring of the guidelines in an acute psychiatric setting.

Results: The process was well accepted by staff and was found useful in monitoring outcomes in a naturalistic setting. The final guidelines proved safe and effective in the acute setting.

Conclusions: The incorporation of a monitoring system for interventions for the management of behavioural disturbance in acute psychiatric settings is beneficial for staff and patients alike.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aggression / drug effects*
  • Aggression / psychology
  • Drug Therapy*
  • Focus Groups
  • Humans
  • Monitoring, Physiologic
  • Practice Guidelines as Topic*
  • Psychotic Disorders / complications
  • Psychotic Disorders / psychology*
  • Safety
  • Treatment Outcome